Lisa Francesca Licitra

机构：University of Milan, Fondazione IRCCS Istituto Nazionale dei Tumori · ORCID：0000-0003-0623-4118

发表论文 961 篇 · 总被引 42455 次 · h-index 88

代表论文

• Pembrolizumab With or Without Lenvatinib as First-Line Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Phase III LEAP-010 Study (2026 · Journal of Clinical Oncology · 被引 3)
• Olfactory carcinoma: a distinct high-grade neuroepithelial carcinoma of the sinonasal tract (2026 · Otorhinolaryngology · 被引 1)
• Final analysis of the investigator-initiated randomized study of anti–PD-L1 durvalumab (durva) with radiation versus chemoradiation (CRT) for intermediate-risk HPV-positive (HPV+) locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC): Canadian Cancer Trials Group (CCTG) HN.9 (EORTC 1740-HNCG). (2026 · Journal of Clinical Oncology · 被引 1)
• Fragmenting the future with FLARE: a comprehensive fragmentomics pipeline based on long-read nanopore sequencing (2026 · Frontiers in Genetics · 被引 1)
• Risk of employment separation among workers with head and neck cancer: a longitudinal cohort study in Turin (2026 · Supportive Care in Cancer)
• Supplementary Data S1 from Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer (2026)